21st Century Oncology chooses Elekta for replacement of radiation therapy

Elekta announces that 21st Century Oncology, the largest radiation oncology provider in the U.S., will replace several of its existing linear accelerators, as well as treatment planning software and oncology information systems, with advanced cancer treatment solutions from Elekta.

The agreement includes Elekta's Versa HD linear accelerators, which combines high definition dynamic radiosurgery and precision radiation therapy treatments throughout the body in a single platform. It also includes Elekta's MOSAIQ oncology information system – the Best in KLAS award winner – that enables optimization in health care practices through intelligent automation and actionable analytics. 21st Century Oncology will also upgrade to Monaco, a state-of-the-art treatment planning solution that powers efficient high definition treatment planning with gold-standard accuracy.

Gustavo Olivera, PhD, 21st Century Oncology's Chief Technology Officer, and Dr. Arie Dosoretz, a 21st Century Oncology member of the Office of the Chief Medical Officer, who oversees clinical operations, says: "Elekta's portfolio is well aligned with our strategic needs. Our partnership offers us a tremendous opportunity to update our domestic and international fleet of machines and continue to adapt our clinical offerings to an ever-evolving field. We are excited to implement our vision together now and in the years to come."

USD 22 million has been booked in the second quarter of Elekta's fiscal year 2017/18. First deliveries of the new order are scheduled to begin in April, 2018, to centers in the USA.